Immunometabolic Therapeutic Targets of Graft-versus-Host Disease (GvHD)

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative option in the treatment of aggressive malignant and non-malignant blood disorders. However, the benefits of allo-HSCT can be compromised by graft-versus-host disease (GvHD), a prevalent and morbid complication of allo-HSCT....

Descripción completa

Detalles Bibliográficos
Autores principales: Mhandire, Kudakwashe, Saggu, Komalpreet, Buxbaum, Nataliya Prokopenko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619522/
https://www.ncbi.nlm.nih.gov/pubmed/34822394
http://dx.doi.org/10.3390/metabo11110736

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8619522/
https://www.ncbi.nlm.nih.gov/pubmed/34822394
http://dx.doi.org/10.3390/metabo11110736

Ejemplares similares